Ranok Therapeutics
Ranok Therapeutics is a biotechnology company that is pioneering an innovative targeted protein degradation technology.
Based based in Asia-Pacific (APAC), Ranok Therapeutics works in biotechnology, founded in 2018.
Ranok Therapeutics is positioned in biotechnology, a segment that rewards a clear, focused offering.
Its base of operations is Asia-Pacific (APAC).
It is recorded at the Series_B stage.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $50M in funding.
| Sector | Biotechnology |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2018 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $50,000,000 |
Website: www.ranoktherapeutics.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account